Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of hypertension, announced today the closing of a $50 million Series B equity financing. The time has arrived to make ABPM a true standard of care. Biobeat secures $50M to […]
SetPoint Medical is offering patients with the autoimmune disorder rheumatoid arthritis something close to a cure. The company’s SetPoint System—which was FDA approved in July—is a small neck implant that gives an electrical jolt for one minute a day to the vagus nerve, and has been shown to help regulate the body’s immune response. “This […]
Sofinnova Partners leads premier investor syndicate backing Galvanize’s breakthrough pulsed electric field (PEF) platform—a first-of-its-kind, non-drug approach targeting solid tumors and chronic bronchitis, the leading cause of COPD. Galvanize (“Galvanize”) Therapeutics, Inc, a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease successfully raised an oversubscribed $100 million Series C […]
The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease. The Food and Drug Administration on Wednesday approved a medical device that offers new hope to patients incapacitated by rheumatoid arthritis, a chronic condition that afflicts 1.5 million Americans and is often resistant to treatment. The […]
VALENCIA, Calif.–(BUSINESS WIRE)–SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, announced that it has raised $140 million in private financing, that includes $25 million in the second tranche of its Series C financing, as well as $115 million in its Series D financing, co-led by Elevage Medical Technologies […]
FDA awards Breakthrough Device Designation to FIRE1’s Norm™ system DUBLIN–FIRE1, a leading connected medical device solutions company, today announced the successful completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. FIRE1’s Norm™ heart failure management system offers a groundbreaking approach […]
This Announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation No. 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended (“EUWA“) and as it may be modified from time to time by or under domestic law including, but not limited to, by the Market Abuse (Amendment) (EU […]
Cambridge, UK, and Boston MA, USA, 16 October 2024: Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing round (circa £57 million). The fundraise was led by Elevage Medical Technologies, backed by Patient Square Capital, and joined by British Patient Capital, […]
New investor Elevage Medical Technologies leads funding round with Cormorant Asset Management and Warren Point Capital joining the investor syndicate FREMONT, Calif.–(BUSINESS WIRE)–Moximed, an innovative medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced the closing on $61 million of Series D preferred stock […]
Firm adds to its team with a new Board Member and two new V.P. hires AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ — Elevage Medical Technologies (“Elevage”), a portfolio company of Patient Square Capital, dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board. Vice-Presidents Suchira Sharma and Peter […]
Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk BOSTON–(BUSINESS WIRE)– Elucid, a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding. The round was led by Elevage Medical Technologies, with additional participation […]
$300 million investment commitment from Patient Square Capital MENLO PARK, CA, May 1, 2023 – Patient Square Capital (“Patient Square”), a leading health care investment firm, today announced the formation of Elevage Medical Technologies (“Elevage”), a new portfolio company to support the growth of promising medical device companies by providing capital and deep strategic expertise. Elevage will […]
